Timothy Sullivan Net Worth & Insider Trades
Timothy Sullivan - Chief Financial Officer, Apellis Pharmaceuticals, Inc
What is Timothy Sullivan's Net Worth?
The current estimated net worth of Apellis Pharmaceuticals, Inc's Chief Financial Officer, Timothy Sullivan, is estimated to be about $1.05M . Timothy Sullivan owns about 11,699 units of Apellis Pharmaceuticals, Inc common stock. In the last 4 years at Apellis Pharmaceuticals, Inc, Timothy Sullivan has sold an estimated value of $107.26K worth.
What is Timothy Sullivan's Past Insider Trading?
Timothy Sullivan's largest purchase order was 11,699 units , worth over $347.63K on September 3, 2019. In total, Timothy Sullivan has made about 10 transactions over 4 years of their time at Apellis Pharmaceuticals, Inc. Timothy Sullivan usually trades in February, with the busiest year in 2021 and 2022.
Timothy Sullivan
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Timothy Sullivan's Salary in 2020?
As Chief Financial Officer of Apellis Pharmaceuticals, Inc, Timothy Sullivan has a total base salary of $430,269 . Timothy Sullivan received compensation valued at about $3,485,149 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of a bonus of $244,688 , stock awards of $518,129 , option awards of $2,279,063 , and other compensation of $13,000 .
What is Timothy Sullivan's' Mailing Address?
- Mailing address is 800 Boylston St., Suite 3310 Prudential Tower C/o Aju Ib Investment Boston MA 02199 MA
Apellis Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Cedric Francois, M.D., Ph.D. | 2020 | $618,769 | $429,687 | $1,523,844 | $6,703,125 | - | $9,275,425 |
| Cedric Francois, M.D., Ph.D. | 2019 | $560,019 | $427,893 | - | $3,279,270 | - | $4,267,182 |
| Cedric Francois, M.D., Ph.D. | 2018 | $550,000 | $381,562 | - | $3,127,600 | $15,378 | $4,074,540 |
| Timothy Sullivan | 2020 | $430,269 | $244,688 | $518,129 | $2,279,063 | $13,000 | $3,485,149 |
| Timothy Sullivan | 2019 | $386,423 | $214,730 | - | $1,108,650 | $9,500 | $1,719,303 |
| Timothy Sullivan | 2018 | $380,000 | $190,000 | - | $279,250 | $10,502 | $859,752 |
| Pascal Deschatelets, Ph.D. | 2020 | $423,500 | $239,062 | $415,594 | $1,828,125 | $11,801 | $2,918,082 |
| Pascal Deschatelets, Ph.D. | 2019 | $404,077 | $252,608 | - | $1,108,650 | $55,893 | $1,821,228 |
| Pascal Deschatelets, Ph.D. | 2018 | $400,000 | $225,000 | - | $1,228,700 | $8,657 | $1,862,357 |
| Nur Nicholson | 2020 | $138,462 | $150,068 | - | $2,648,750 | $84,874 | $3,022,154 |
| Adam Townsend | 2020 | $430,038 | $217,500 | $415,594 | $1,828,125 | $9,750 | $2,901,007 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1492422/000119312521126688/d887358ddef14a.htm
What are Apellis Pharmaceuticals, Inc's Past Insider Trades?
Apellis Pharmaceuticals, Inc's most recent insider trade came on August 12, 2022 by Adam Townsend who sold 12,500 units worth $837.5K . In the last 5 years, insiders at Apellis Pharmaceuticals, Inc have sold an estimated value of $51.6M and bought an estimated value of $95.27M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Federico Grossi, CHIEF MEDICAL OFFICER, Cedric Francois, Chief Executive Officer, and Alec MacHiels, Director .
Apellis Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||